Christine I. Fortier
Contest, 14280, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C2254 Variant.
Journal: Pathogens (Basel, Switzerland)
Published: March 24, 2022
Equine Herpesvirus 1 Variant and New Marker for Epidemiologic Surveillance, Europe, 2021.
Journal: Emerging infectious diseases
Published: September 21, 2021
Screening of potential antiviral molecules against equid herpesvirus-1 using cellular impedance measurement: Dataset of 2,891 compounds.
Journal: Data in brief
Published: September 11, 2020
Identification of antiviral compounds against equid herpesvirus-1 using real-time cell assay screening: Efficacy of decitabine and valganciclovir alone or in combination.
Journal: Antiviral research
Published: June 12, 2020
Further Evidence for in Utero Transmission of Equine Hepacivirus to Foals.
Journal: Viruses
Published: September 26, 2019
Last Updated: 09/26/2026